Improving data on pharmaceutical expenditure in hospitals and other health care settings

David Morgan and Fan Xiang
Additional contact information
David Morgan: OECD
Fan Xiang: OECD

No 139, OECD Health Working Papers from OECD Publishing

Abstract: As a key component of health care, a full understanding of how much is spent on prescription medicines is increasingly important. Only a partial understanding of total expenditures across health systems is currently possible, as reporting is often limited to medicines dispensed in community pharmacies. However, spending on pharmaceuticals used elsewhere in the health sector, particularly in hospitals, constitutes a significant and growing proportion of the overall resources allocated to medicines. This report aims to improve the coverage and quality of data on total pharmaceutical spending across the whole health sector, by reviewing current practices, and recommending a set of definitions, concepts and guidance under the framework of A System of Health Accounts 2011. Countries are encouraged to apply these guidelines in their future reporting of pharmaceutical expenditures, as part of their annual health accounts data production.

Keywords: Data; Health Systemes; Pharmaceutical spending; Prescription medicines (search for similar items in EconPapers)
JEL-codes: I I10 I11 I19 (search for similar items in EconPapers)
Date: 2022-04-27
References: Add references at CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://doi.org/10.1787/6c0d64a2-en (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:oec:elsaad:139-en

Access Statistics for this paper

More papers in OECD Health Working Papers from OECD Publishing Contact information at EDIRC.
Bibliographic data for series maintained by ().